Your browser doesn't support javascript.
loading
Lactate induces tumor progression via LAR motif-dependent Yin-Yang 1 degradation.
Du, Shujuan; Chen, Xiaoting; Han, Xiao; Wang, Yuyan; Yu, Dan; Li, Ying; Zhu, Caixia; Tong, Yin; Gao, Shujun; Wang, Junwen; Wei, Fang; Cai, Qiliang.
Afiliação
  • Du S; Fudan University, Shanghai, China.
  • Chen X; Fudan University, Shanghai, China.
  • Han X; Fudan University, Shanghai, China.
  • Wang Y; Fudan University, Shanghai, China.
  • Yu D; University of Hong Kong, Hong Kong, Hong Kong.
  • Li Y; Fudan University, Shanghai, China.
  • Zhu C; Fudan University, Shanghai, China.
  • Tong Y; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China.
  • Gao S; Fudan University, Shanghai, China.
  • Wang J; Mayo Clinic, Scottsdale, Arizona, United States.
  • Wei F; Shanghai Jiao Tong University, Shanghai, China.
  • Cai Q; Fudan University, Shanghai, China.
Mol Cancer Res ; 2024 Jun 18.
Article em En | MEDLINE | ID: mdl-38888574
ABSTRACT
Metabolic reprogramming of aerobic glycolysis contributes to tumorigenesis. High plasma lactate is a critical regulator in the development of many human malignancies; however, the underlying molecular mechanisms of cancer progression in the response to lactate (LA) remain elusive. Here we show that reduction of Yin-Yang 1 (YY1) expression correlated with high LA commonly occurs in various cancer cell types, including B-lymphoma and cervical cancer. Mechanistically, LA induces YY1 nuclear export and degradation via HSP70-mediated autophagy adjacent to mitochondria in a Histidine-rich LAR (LA-responsive) motif-dependent manner. Mutation of the LAR motif blocks LA-mediated YY1 cytoplasmic accumulation and in turn enhances cell apoptosis. Furthermore, low expression of YY1 promotes the colony formation, invasion, angiogenesis and growth of cancer cells in response to LA in vitro and in vivo using a murine xenograft model. Taken together, our findings reveal that a key lactate-responsive` element and may serve as therapeutic target for intervening cancer progression. Implications We have shown lactate can induce YY1 degradation via its Histidine-rich LAR motif, and low expression of YY1 promotes cancer cell progression in response to lactate, leading to better prediction of YY1-targeting therapy.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article